Keywords: bb-94, starts, phase, i/ii, cancer, trial, british

BB-94 STARTS PHASE I/II CANCER TRIAL

Article | 14 June 1993

Print This

British Bio-technology Group of the UK has started a Phase I/II trial of its injectable matrix metalloproteinase inhibitor, BB-94, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in